AbCellera Biologics Inc.

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Investing News NetworkYour trusted source for investing success

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

Top 10 Copper-producing Companies (Updated 2024)

7 Biggest Lithium-mining Companies

Trump and the Gold Standard (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

When Will Copper Go Up? (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Where Does Tesla Get its Lithium? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

Galan Increases Total Mineral Resource by 18% to 8.6Mt LCE @ 859mg/L Lithium

Canadian North Resources Inc. Provides an Update on its Metallurgical Testing Programs at the Ferguson Lake Project

CleanTech Lithium - CEOL Applications

Operational and Financial Update

Lancaster Resources Closing of Spin-Off of Nelson Lake Copper Corp.

Helium Evolution Confirms Additional Drilling of Up to 9 New Wells on Joint Land and Provides Operations Update

Fireweed Metals

Galan Lithium

Elixir Energy

NorthStar Gaming Holdings

2024 Rare Earths Outlook: Australia Edition

2024 Copper Outlook Report

2024 Battery Metals Outlook: Australia Edition

Nickel Investor Report

MT Survey Outlines Large Undrilled Conductive Anomalies and an Extensive Host Horizon at BAGB

First Parcel of Ore for 2024 to be Processed Mid-April

Health House Australia and Corporate Update

Gold and Nickel Exploration Update

Deep Drilling Hits Visible Gold Over 1km Deep Below Never Never Gold Deposit

AbCellera Biologics Inc.